These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
893 related items for PubMed ID: 24434637
1. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy. Sun A, Cheng Y, Zhang Y, Zhang Q, Wang S, Tian S, Zou Y, Hu K, Ren J, Ge J. J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637 [Abstract] [Full Text] [Related]
7. Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK/p53 pathway in mice. Sun A, Zou Y, Wang P, Xu D, Gong H, Wang S, Qin Y, Zhang P, Chen Y, Harada M, Isse T, Kawamoto T, Fan H, Yang P, Akazawa H, Nagai T, Takano H, Ping P, Komuro I, Ge J. J Am Heart Assoc; 2014 Sep 18; 3(5):e000779. PubMed ID: 25237043 [Abstract] [Full Text] [Related]
8. Mitochondrial aldehyde dehydrogenase obliterates endoplasmic reticulum stress-induced cardiac contractile dysfunction via correction of autophagy. Zhang B, Zhang Y, La Cour KH, Richmond KL, Wang XM, Ren J. Biochim Biophys Acta; 2013 Apr 18; 1832(4):574-84. PubMed ID: 23354068 [Abstract] [Full Text] [Related]
9. Acetaldehyde dehydrogenase 2 (ALDH2) deficiency exacerbates pressure overload-induced cardiac dysfunction by inhibiting Beclin-1 dependent autophagy pathway. Shen C, Wang C, Fan F, Yang Z, Cao Q, Liu X, Sun X, Zhao X, Wang P, Ma X, Zhu H, Dong Z, Zou Y, Hu K, Sun A, Ge J. Biochim Biophys Acta; 2015 Feb 18; 1852(2):310-8. PubMed ID: 25086229 [Abstract] [Full Text] [Related]
10. Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function. Zhang Y, Babcock SA, Hu N, Maris JR, Wang H, Ren J. BMC Med; 2012 Apr 23; 10():40. PubMed ID: 22524197 [Abstract] [Full Text] [Related]
11. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. He L, Liu B, Dai Z, Zhang HF, Zhang YS, Luo XJ, Ma QL, Peng J. Eur J Pharmacol; 2012 Mar 05; 678(1-3):32-8. PubMed ID: 22266491 [Abstract] [Full Text] [Related]
12. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Wang X, Wang XL, Chen HL, Wu D, Chen JX, Wang XX, Li RL, He JH, Mo L, Cen X, Wei YQ, Jiang W. Biochem Pharmacol; 2014 Apr 01; 88(3):334-50. PubMed ID: 24522112 [Abstract] [Full Text] [Related]
13. Aldehyde dehydrogenase 2 knockout accentuates ethanol-induced cardiac depression: role of protein phosphatases. Ma H, Yu L, Byra EA, Hu N, Kitagawa K, Nakayama KI, Kawamoto T, Ren J. J Mol Cell Cardiol; 2010 Aug 01; 49(2):322-9. PubMed ID: 20362583 [Abstract] [Full Text] [Related]
14. Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1α. Hu N, Ren J, Zhang Y. Oncotarget; 2016 Nov 22; 7(47):76398-76414. PubMed ID: 27634872 [Abstract] [Full Text] [Related]
15. Aldehyde dehydrogenase 2 activation ameliorates cyclophosphamide-induced acute cardiotoxicity via detoxification of toxic aldehydes and suppression of cardiac cell death. Liu W, Zhai X, Wang W, Zheng B, Zhang Z, Fan X, Chen Y, Wang J. J Mol Cell Cardiol; 2018 Aug 22; 121():134-144. PubMed ID: 29981795 [Abstract] [Full Text] [Related]
16. Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1. Gomes KM, Bechara LR, Lima VM, Ribeiro MA, Campos JC, Dourado PM, Kowaltowski AJ, Mochly-Rosen D, Ferreira JC. Int J Cardiol; 2015 Jan 20; 179():129-38. PubMed ID: 25464432 [Abstract] [Full Text] [Related]
17. Mitochondrial aldehyde dehydrogenase protects against doxorubicin cardiotoxicity through a transient receptor potential channel vanilloid 1-mediated mechanism. Ge W, Yuan M, Ceylan AF, Wang X, Ren J. Biochim Biophys Acta; 2016 Apr 20; 1862(4):622-634. PubMed ID: 26692169 [Abstract] [Full Text] [Related]
18. ULK1-regulated autophagy: A mechanism in cellular protection for ALDH2 against hyperglycemia. Liu M, Lu S, He W, Zhang L, Ma Y, Lv P, Ma M, Yu W, Wang J, Zhang M, Zhang Y, Li Y. Toxicol Lett; 2018 Feb 20; 283():106-115. PubMed ID: 29128638 [Abstract] [Full Text] [Related]
19. Aldehyde dehydrogenase 2 deficiency blunts compensatory cardiac hypertrophy through modulating Akt phosphorylation early after transverse aorta constriction in mice. Xia G, Fan F, Liu M, Wang S, Wu J, Shen C, Han S, Wang C, Jia J, Zou Y, Hu K, Ge J, Sun A. Biochim Biophys Acta; 2016 Sep 20; 1862(9):1587-93. PubMed ID: 27239698 [Abstract] [Full Text] [Related]
20. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. van Almen GC, Swinnen M, Carai P, Verhesen W, Cleutjens JP, D'hooge J, Verheyen FK, Pinto YM, Schroen B, Carmeliet P, Heymans S. J Mol Cell Cardiol; 2011 Sep 20; 51(3):318-28. PubMed ID: 21624372 [Abstract] [Full Text] [Related] Page: [Next] [New Search]